Marché du traitement de la vessie hyperactive – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00004082
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 209
Buy Now

Le marché du traitement de la vessie hyperactive devrait passer de 4 295,93 millions de dollars US en 2021 & ; On estime qu'il croîtra à un TCAC de 3,1 % de 2022 à 2028.



La vessie hyperactive (VSA) est l'envie fréquente et soudaine d'uriner, qui peut être difficile à contrôler. L'hyperactivité vésicale peut être causée par un traumatisme abdominal, une infection, des lésions nerveuses et certains médicaments. L'hyperactivité vésicale est fréquente chez les personnes âgées de 65 ans et plus. Les femmes peuvent avoir OAB après 45 ans. Le traitement comprend la modification de certains comportements, la prise de médicaments et la stimulation nerveuse.



Le le marché du traitement de la vessie hyperactive est segmenté en pharmacothérapie, le type de maladie et la géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient & Afrique et Sud & Amérique centrale. Le rapport sur le marché du traitement de la vessie hyperactive offre des informations et une analyse approfondie du marché, en mettant l'accent sur des paramètres tels que les tendances du marché, la dynamique du marché et l'analyse concurrentielle des principaux acteurs du marché mondial.



Insights stratégiques



Régions lucratives pour le marché du traitement de la vessie hyperactive

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment by pharmacotherapy led the overactive bladder treatment market?

The mirabegron segment held the largest share of the market in 2021. However, neurostimulation is expected to grow at the highest CAGR during the forecast period.

Which region is projected to be the fastest-growing region in the global overactive bladder treatment market?

The Asia Pacific is expected to be the fastest-growing region in the overactive bladder treatment market over the forecast period due to the rising geriatric population, increasing urinary incontinence cases, and a surge in product launches.

What is the market CAGR value of the overactive bladder treatment market during the forecast period?

The CAGR value of the overactive bladder treatment market during the forecasted period of 2022-2028 is 3.1%.

What is the estimated overactive bladder treatment market size in 2021?

The overactive bladder treatment market is estimated to be valued at US$ 4,295.93 million in 2021.

What are the growth estimates for the overactive bladder treatment market till 2028?

The overactive bladder treatment market is expected to be valued at US$ 5,333.92 million in 2028.

Who are the major players in the overactive bladder treatment market across the globe?

The overactive bladder treatment market majorly consists of the players, such as Alembic Pharmaceuticals Limited, Astellas Pharma Inc; Pfizer Inc; AbbVie Inc; Teva Pharmaceutical Industries Ltd; Endo Pharmaceuticals Inc; Hisamitsu Pharmaceutical Co., Inc; Medtronic Plc; Colorado Urology Associates, PLLC; Axonics Modulation Technologies, Inc.

What are the driving factors for the global overactive bladder treatment market across the world?

The factors that are driving the growth of the overactive bladder treatment market are urinary tract infections (UTI) which lead to increased activity in the bladder wall muscles, causing symptoms like an overactive bladder. The bacteria causing UTIs reside in the lining of urothelial cells, and they attack the host body when their innate immunity is low. Individuals with recurrent UTIs are found to have voiding dysfunction and detrusor overactivity, and these functional abnormalities may further damage the integrity of the urothelial barrier. The increasing prevalence of UTIs, coupled with the association of UTIs with overactive bladder, is one of the prominent factors contributing to the overactive bladder treatment market growth.

What are overactive bladder treatments?

The sudden need to urinate causes a problem with bladder dysfunction. An overactive bladder may affect how often you pee and your urgency. Causes include abdominal trauma, infection, nerve damage, medications, and certain fluids. Treatment includes changing certain behaviors, medications, and nerve stimulation. Overactive bladder is common in people aged 65 and older. Women may have OAB at a younger age, usually around 45.

The List of Companies -Overactive Bladder Treatment Market

  1. Alembic Pharmaceuticals Limited
  2. Astellas Pharma Inc
  3. Pfizer Inc
  4. AbbVie Inc
  5. Teva Pharmaceutical Industries Ltd
  6. Endo Pharmaceuticals Inc.
  7. Hisamitsu Pharmaceutical Co.,Inc
  8. Medtronic Plc
  9. Colorado Urology Associates, PLLC
  10. Axonics Modulation Technologies, Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports